Skip to content
Art, Medical Health Aged Care

HIV Science as Art exhibit unites world-class art with cutting-edge HIV science.

ViiV Healthcare Australia 2 mins read

BRISBANE, Monday 24 July 2023. For Immediate Release

  • HIV Science as Art is an exhibit that will highlight new and innovative science through art 23 July - 5 August 2023 at Metro Arts, 97 Boundary Street, West End, Brisbane, Australia.

HIV Science as Art brings the spectacular scientific advancements in HIV to life through the work of 12 extraordinary artists living with HIV from around the world. 

As distinguished scientists gather in Brisbane for the 12th International Conference on HIV Science (IAS 2023), the HIV Science as Art exhibition will take place at Metro Arts, meters away from the conference centre.

Twelve eminent scientists (who will be presenting at the conference) have been matched with an artist living with HIV to create a collaborative artwork over a 90-day period (March-May 2023). All selected artists received a commission to create an original piece of work in conversation with their companion scientist that reflects the concepts of their scientific work.

The final works, which will include everything from fashion design to painting to photography to sculpture, will be for sale alongside catalogues, high-quality art prints, and postcard sets. All proceeds will be used to support programs and services for people living with HIV in the Asia Pacific region.

Participating scientists include Dr Ya-Chi Ho (Yale University), Dr Claudia Cortez (University of Chili) and Dr Ryan Whitacre (Graduate Institute, Geneva) and the artists include Tim Tate (USA), Kairon (Ren-Kai) Liu (Taiwan) and Dani Marti (Spain/Australia).

HIV Science as Art is a project of the National Association of People Living with HIV Australia (NAPWHA) in partnership with the Asia Pacific Coalition on Male Sexual Health (APCOM), Holdsworth House Medical Practice, Metro Arts, the International AIDS Society (IAS), Queensland Positive People (QPP) and UNAIDS.

Funding for this project has been provided by ViiV Healthcare through an unrestricted educational grant.


Contact details:

Brent Allan

HIV Science as Art Project Coordinator

+(61) 427 682 867

[email protected]

Emma Oxenburgh

Senior Communications Officer NAPWHA

+(61) 413 535 632

[email protected] 

Juliette Bagwell

Palin Communications

+(61) 433 336 487

juliette@palin.com.au

Media

More from this category

  • Medical Health Aged Care
  • 23/12/2025
  • 06:00
Monash University

Look after each other this festive season, experts urge, as alcohol harms surge

As Australians head into the festive season, health experts are urging people to plan ahead and look after each other, with new data showing a significant spike in alcohol related harms over the Christmas and New Year period. The analysis of 2023 ambulance data from the National Ambulance Surveillance System (NASS) at Turning Point and Monash University has revealed alcohol- ambulance attendances increased by an average of 25 percent in most states during the final two weeks of the year compared to the rest of the year. The analysis included data from Victoria, New South Wales, Tasmania, Queensland, the Australian…

  • Contains:
  • Medical Health Aged Care
  • 22/12/2025
  • 14:43
Dementia Australia

Dementia Australia celebrates Nic Tremaine’s extraordinary 47,000km ride for dementia awareness

Dementia Australia is preparing to celebrate cyclist Nic Tremaine as he approaches the finish line of Distance 4 Dementia - a solo, unsupported ride around Australia over 365 days. On New Year’s Eve,Nic will roll into Sydney, completing an extraordinary effort inspired by his mum Marilyn’s dementia diagnosis and a dedication to raising awareness and vital funds for Dementia Australia. Dementia Australia CEO Professor Tanya Buchanan said she is in awe ofNic who started his journey on 1 January 2025, setting out to ride the earth’s circumference and to spark conversations about dementia. “Over the past 12 months,Nic has averaged…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 22/12/2025
  • 08:55
INOVIQ Ltd (ASX: IIQ)

INOVIQ’s CAR-EXOSOMES DELIVER POSITIVE IN VIVO EFFICACY AND SAFETY RESULTS IN BREAST CANCER

Key Facts: · Superior Tumour Inhibition – INOVIQ’s CAR-NK-EV therapeutic candidate achieved 61.5% tumour reduction over 28 days, outperforming unmodified NK-EVs · 100% Survival…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.